Ultragenyx Pharmaceutical Inc Company
Ultragenyx Pharmaceutical develops therapeutics for rare diseases, sometimes referred to as Orphan products. Ultragenyx is a efficient and effective development strategies are essential for success in the rare disease space, in which information may be incomplete or ambiguous, and few development precedents exist.
Industry:
Genomic and Epigenominc Instabillity
Headquarters:
United States
Register and Claim Ownership